Skip to main content
OpenTrials
Completed

NCT Number: NCT01701271

Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females

The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Androgenetic Alopecia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Androgenetic Alopecia Alopecia Hair Diseases Hypotrichosis Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

George Mexis

Athens, 11253, Greece

About this study

This study verifies whether the tested product has any efficacy in the treatment of Androgenetic Alopecia.

  • The evaluated product (Hair Loss prevention Lotion) is called:MEXIS, MPAF, M6S PATENT.
  • 20 volunteers both men and women suffering from hair loss both in parties and over the entire scalp with age between 18 and 70 years have been selected for this test .
  • Samples of the product have been applied following their usual use: as they are.
  • On the selecting volunteers have been used:
  • The pull test by pulling with fingers of some hair and counting them to estimate the evolution of the pathology.
  • A sebum-meter to check the presence of scales on the scalp.
  • A polarized light video-camera to check the redness of the scalp and to have a picture of hair and scalp.
  • Volunteers were also asked about:
  • Fluffiness
  • Sheen
  • Itching
  • Presence of scales on scalp
  • Oily hair
  • Product's acceptability
  • The readings are taken at 0 time (basal value), after 15 days (t15), 30 days (t30), 45 days (t45), 45 days (t45), 60 days (t60) and 90 days (t90) by the experimenter in the medical studio. Then they analyzed and reported in a graph.
  • Summarizing tables and graphs of the data were taken during experimentation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Good state of general health
  • Suffering from hair loss
  • No pharmacological treatment in progress
  • Promise not to change the usual daily routine
  • No atopy in the anamnesis

Exclusion criteria

  • Illness
  • Good state of hair
  • Pharmacological treatment in progress
  • Denial of the continuance of the usual daily routine
  • Atopy in the anamnesis

Treatment and study plan

Hair loss prevention lotion

Other

For greatest problems 20 drops on the scalp per day for 3 months. For minor problems 10 drops on the scalp three times per week for 3 months.

Primary outcomes

  1. Change of the Amount of Hair Loss in a Pull Test

    Time frame: baseline and 90 days

    Measurement of the decrease of hair loss by pull test and pulling some hair with the fingers.

    Measurements estimated and reported every 15 days. The Measure reports decrease in fallen hair

  2. Change of the Density of the Hair on a Polarized Light Video-camera as a Measure of Efficacy.

    Time frame: baseline and 90 days

    Number of hair was assessed for each participant with a polarized light video-camera every 15 days for a total of 6 assessments

Secondary outcomes

  1. Change of Sebum on a Sebum-meter

    Time frame: baseline and 90 days

    Measurements checked and reported every 15 days of the decrease of existing sebum on the scalp of the volunteers with a sebum-meter.

Sponsors and collaborators

Lead sponsor

Mexis George

Other

Registry information

Official study title

Evaluation of the Efficacy of the Cosmetic Lotion M.P.A.F. (Mixture of Paraffin, Alcohol and Fur) MEXIS PATENT in the Treatment of Androgenetic Alopecia by Decreasing of Hair Loss and Strengthening and Thickening of Hair in Males and Females.

Acronym: MEXISPATENT

Important dates

Study start
2001
Primary completion
2001
Study completion
2001
First posted
Oct 5, 2012
Registry last updated
Feb 17, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.